BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25043303)

  • 1. Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity.
    Ng KY; Yin T; Machida K; Wu YI; Mayer BJ
    Oncogene; 2015 May; 34(20):2650-9. PubMed ID: 25043303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteins that bind the Src homology 3 domain of CrkI have distinct roles in Crk transformation.
    Zheng J; Machida K; Antoku S; Ng KY; Claffey KP; Mayer BJ
    Oncogene; 2010 Dec; 29(48):6378-89. PubMed ID: 20729917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dok1 and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation, proliferation and Ras/Erk activation.
    Oki S; Limnander A; Yao PM; Niki M; Pandolfi PP; Rothman PB
    Cell Cycle; 2005 Feb; 4(2):310-4. PubMed ID: 15655368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Abl phosphorylates Dok1 to promote filopodia during cell spreading.
    Woodring PJ; Meisenhelder J; Johnson SA; Zhou GL; Field J; Shah K; Bladt F; Pawson T; Niki M; Pandolfi PP; Wang JY; Hunter T
    J Cell Biol; 2004 May; 165(4):493-503. PubMed ID: 15148308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crk family adaptor proteins trans-activate c-Abl kinase.
    Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
    Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.
    Sriram G; Reichman C; Tunceroglu A; Kaushal N; Saleh T; Machida K; Mayer B; Ge Q; Li J; Hornbeck P; Kalodimos CG; Birge RB
    Oncogene; 2011 Nov; 30(46):4645-55. PubMed ID: 21602891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel member of the DOK family that binds and modulates Abl signaling.
    Cong F; Yuan B; Goff SP
    Mol Cell Biol; 1999 Dec; 19(12):8314-25. PubMed ID: 10567556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals.
    Antoku S; Mayer BJ
    J Cell Sci; 2009 Nov; 122(Pt 22):4228-38. PubMed ID: 19861495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.
    Mihrshahi R; Brown MH
    J Immunol; 2010 Dec; 185(12):7216-22. PubMed ID: 21078907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
    Ren R; Ye ZS; Baltimore D
    Genes Dev; 1994 Apr; 8(7):783-95. PubMed ID: 7926767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
    Mayer BJ; Baltimore D
    Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Dok-1 and Dok-2 in leukemia suppression.
    Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP
    J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of c-Crk II on the negative regulatory Tyr222 mediates nerve growth factor-induced cell spreading and morphogenesis.
    Escalante M; Courtney J; Chin WG; Teng KK; Kim JI; Fajardo JE; Mayer BJ; Hempstead BL; Birge RB
    J Biol Chem; 2000 Aug; 275(32):24787-97. PubMed ID: 10825157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.
    Dunant NM; Wisniewski D; Strife A; Clarkson B; Resh MD
    Cell Signal; 2000 May; 12(5):317-26. PubMed ID: 10822173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
    Jung JH; Pendergast AM; Zipfel PA; Traugh JA
    Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes.
    Kain KH; Klemke RL
    J Biol Chem; 2001 May; 276(19):16185-92. PubMed ID: 11279004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Abl kinase regulates the protein binding activity of c-Crk.
    Feller SM; Knudsen B; Hanafusa H
    EMBO J; 1994 May; 13(10):2341-51. PubMed ID: 8194526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.